Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack

Richard F Schlenk^{1

2}, Sonia Jaramillo², Carsten Müller-Tidow²

Affiliations

¹ NCT-Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany richard.schlenk@nct-heidelberg.de.
² Department of Hematology, Oncology, and Rheumatology at Heidelberg University Hospital, University of Heidelberg, Germany.

Editorial

Richard F Schlenk et al. Haematologica. 2018 Oct.

. 2018 Oct;103(10):1579-1581.

doi: 10.3324/haematol.2018.200485.

Richard F Schlenk^{1

2}, Sonia Jaramillo², Carsten Müller-Tidow²

¹ NCT-Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany richard.schlenk@nct-heidelberg.de.
² Department of Hematology, Oncology, and Rheumatology at Heidelberg University Hospital, University of Heidelberg, Germany.

No abstract available

Comment on

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial.
Burnett AK, Das Gupta E, Knapper S, Khwaja A, Sweeney M, Kjeldsen L, Hawkins T, Betteridge SE, Cahalin P, Clark RE, Hills RK, Russell NH; UK NCRI AML Study Group. Burnett AK, et al. Haematologica. 2018 Oct;103(10):1654-1661. doi: 10.3324/haematol.2018.189514. Epub 2018 Jul 5. Haematologica. 2018. PMID: 29976746 Free PMC article. Clinical Trial.

1. Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017; 129(4):424–447. - PMC - PubMed
1. Schlenk RF, Müller-Tidow C, Benner A, Kieser M. Relapsed/refractory acute myeloid leukemia: any progress? Curr Opin Oncol. 2017; 29(6):467–473. - PubMed
1. Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med. 1994; 331(14):896–903. - PubMed
1. Schlenk RF, Jaramillo S, Müller-Tidow C. What’s new in consolidation therapy in AML? Semin Hematol. 2018; In press. - PubMed
1. NCCN Guidelines https://www.nccn.org/store/login/login.aspx? ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf